How Rare Is Congenital Sucrase-Isomaltase Deficiency?

If your doctor told you Congenital Sucrase-Isomaltase Deficiency (CSID) is extremely rare, they are technically right about the most severe, classic form of the condition. However, medical experts now recognize that genetic variants affecting the sucrase-isomaltase enzyme exist on a spectrum. Because the symptoms overlap significantly with other common digestive disorders, many people who have a partial enzyme deficiency or a milder form of the condition experience delays in getting an accurate diagnosis.

Bottom Line: If you have symptoms similar to Irritable Bowel Syndrome (IBS), a form of sucrase-isomaltase deficiency is one possible explanation, but symptoms alone cannot diagnose it. More common causes must also be considered. Always seek prompt medical evaluation if you experience “red flag” symptoms such as blood in your stool, unintentional weight loss, persistent fever, or chronic diarrhea that wakes you up at night.

Understanding the Numbers: How Rare is It?

When estimating how common this condition is, it is important to separate classic severe CSID from milder genetic variants.

• Classic Severe CSID: When looking at the general global population, severe CSID is a rare genetic disorder. Studies evaluating global genetic data estimate the prevalence of classic congenital cases to be between 31 and 58 per million births (roughly 0.003% to 0.006%) ^[1]. This occurs when someone inherits two severe disease-causing genetic variants.
• Populations with Higher Prevalence: In certain populations, variants associated with the condition are much more common. For example, research shows that approximately 2% to 3% of the Greenlandic population carry two copies of a specific Arctic variant associated with reduced enzyme function and an increased risk of CSID ^[2]. This specific variant is also present in other Arctic populations, including Indigenous populations of Alaska, though the exact risk varies by community ^[3][4].

Symptom Overlap and Misdiagnosis

People with CSID lack the digestive enzymes needed to break down sucrose (table sugar) and certain starches, leading to symptoms like chronic diarrhea, bloating, gas, and abdominal pain after meals ^[5][6]. Note: Because these symptoms can overlap with many conditions, patients should not eliminate broad food groups without guidance from a doctor or registered dietitian.

Because these symptoms overlap heavily with Irritable Bowel Syndrome with Diarrhea (IBS-D), it is common for patients to receive an IBS label without further testing ^[5]. This symptom overlap contributes to long diagnostic delays. In one study of pediatric patients, the median delay from the onset of symptoms to an accurate diagnosis was over five years ^[4].

Another study looked at adult patients who were presumed to have IBS with diarrhea or mixed bowel habits and found that 35% had low sucrase-isomaltase activity when tested via an intestinal biopsy ^[5].

Important Context on Biopsies: A biopsy showing low enzyme activity does not automatically mean a person has genetic CSID. Enzyme activity can temporarily drop (secondary deficiency) due to intestinal inflammation, infections, small intestinal bacterial overgrowth (SIBO), or untreated celiac disease. Therefore, this 35% finding does not mean one-third of all people with IBS have a genetic condition; it highlights that enzyme testing can sometimes uncover an alternative explanation for chronic diarrhea.

A Spectrum of Genetic Deficiency

Medical understanding of CSID is evolving into a broader category known as genetic sucrase-isomaltase deficiency (GSID). It is not just a simple “yes or no” condition.

While having two severe genetic mutations is rare, carrying milder genetic variants—known as hypomorphic variants—is more common ^[7]. A hypomorphic variant causes only a partial loss of enzyme function. These partial variants act as risk factors or susceptibility genes. A person carrying one of these variants might not experience the severe symptoms seen in infants with classic CSID (such as failure to thrive, where a baby does not gain weight or grow as expected). Instead, their carbohydrate intolerance might only become noticeable in adulthood, depending on their diet and other intestinal factors ^[7][8].

This evolving understanding means that while the classic, severe form of CSID remains rare, milder genetic risk factors that affect how you digest sugars and starches are more prevalent than the “extremely rare” label implies.